- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03924908
Impact of Virtual Reality Hypnosis on Pain and Anxiety During Dressings Change in Burn Patients
June 25, 2023 updated by: Anne-Françoise Rousseau, University of Liege
Impact of Virtual Reality Hypnosis on Pain and Anxiety During Dressings Change in Burn Patients Treated as Outpatients
Different non-pharmacological techniques, including hypnosis and virtual reality are currently used as complementary tools in the treatment of pain related to burn injury.
A new technique called 'virtual reality hypnosis' (VRH) (Patterson et al., 2004), which encompasses a combination of both tools, is regularly used although its actual function remains unknown to this date.
With the goal to improve our understanding of VRH combination effects, it is necessary to elaborate randomized and controlled research studies in order to understand their actual function in individual's perception.
100 patients who are treated as outpatients for burn care will be randomly assigned to virtual reality or VRH.
Patients will receive one session of one of these techniques during burn dressing change.Physiological parameters will be recorded during dressing change.
Participants will fill in a questionnaire evaluating their tendency to be absorbed and dissociated, and another evaluating their level of perceived immersion.
Their level of anxiety, pain, fatigue and relaxation will be evaluated before and after the session.
A short interview will also be conducted to give participants the opportunity to openly describe their experience.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Audrey Vanhaudenhuyse, PhD
- Email: avanhaudenhuyse@chuliege.be
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Burn patient treated as outpatient
- Burn surface area > or = 5% of the total body surface area
- mainly 2nd degree burn
Exclusion Criteria:
- Psychiatric antecedents
- Claustrophobia
- Heavy hearing
- Visual impairment
- Face burn
- Conjunctivitis
- Consent not obtained
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: VRH
Virtual reality hypnosis
|
Patients will see a 3D film combined with a hypnotic voice during the entire procedure of dressing change
|
Active Comparator: VR
Virtual reality
|
Patients will see a 3D film without any hypnotic voice during the entire procedure of dressing change
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain perception: Visual Analogical Scale (VAS)
Time Frame: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Visual Analogical Scale (VAS) from 0 to 10.
This is a subjective linear scale.
No pain = 0, maximum pain = 10.
|
5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Change in anxiety: Visual Analogical Scale (VAS)
Time Frame: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Visual Analogical Scale (VAS) from 0 to 10.
This is a subjective linear scale.
No anxiety = 0, maximum anxiety = 10.
|
5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Change in fatigue
Time Frame: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Visual Analogical Scale (VAS) from 0 to 10.
This is a subjective linear scale.
No fatigue = 0, maximum fatigue = 10.
|
5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Change in relaxation level
Time Frame: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Visual Analogical Scale (VAS) from 0 to 10.
This is a subjective linear scale.
No relaxation = 0, maximum relaxation = 10.
|
5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of absorption at the moment
Time Frame: 5 minutes after dressing change ("time 1")
|
Absorption will be measured as the two components of hypnosis.
We will measure absorption and dissociation using the Visual Analogical Scales (VAS).
VAS is from 0 to 10. 0 is not absorbed and 10 is really absorbed.
When responding to a VAS item, participants will be asked to specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.
|
5 minutes after dressing change ("time 1")
|
Level of dissociation at the moment
Time Frame: 5 minutes after dressing change ("time 1")
|
Dissociation will be measured as the two components of hypnosis.
We will measure absorption and dissociation using the Visual Analogical Scales (VAS).
When responding to a VAS item, participants will be asked to specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.
|
5 minutes after dressing change ("time 1")
|
Time perception
Time Frame: 5 minutes after dressing change ("time 1")
|
We will ask to the patient his perception of time during the session.
|
5 minutes after dressing change ("time 1")
|
Change in heart rate
Time Frame: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Physiological parameter measured using pulse oximeter
|
5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant's tendency to be absorbed and dissociated
Time Frame: At inclusion (Day -2)
|
Tellegen Absorption Scale (TAS).
Participants answer "true" or 'false" at each items (34).
The subject's score is simply the number of items marked "true".
|
At inclusion (Day -2)
|
Participant's opinion about the tool
Time Frame: 5 minutes after dressing change ("time 1")
|
Satisfaction questionnaire created by our lab to understand if patients have a good adherence about the tool or not.
Some items should be marked as "yes" or "not" and some items are marked from 1 ("not at all") to 7 ("enormously")
|
5 minutes after dressing change ("time 1")
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2023
Primary Completion (Estimated)
June 1, 2025
Study Completion (Estimated)
June 1, 2025
Study Registration Dates
First Submitted
April 11, 2019
First Submitted That Met QC Criteria
April 18, 2019
First Posted (Actual)
April 23, 2019
Study Record Updates
Last Update Posted (Actual)
June 27, 2023
Last Update Submitted That Met QC Criteria
June 25, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BurnVR-H
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
MediWound LtdCompletedThermal BurnsUnited States, Israel, Belgium, Czechia, Georgia, Germany, Italy, Romania
-
Sun Yat-sen UniversityCompleted
-
MediWound LtdActive, not recruitingThermal BurnsUnited States, United Kingdom, Spain, Georgia, Belgium, Poland, Germany, Hungary, India, Italy, Netherlands, Romania, Slovakia, Ukraine
-
Virginia Commonwealth UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
St. Justine's HospitalRecruiting
Clinical Trials on VRH
-
Clinique Saint-Jean, BruxellesUniversity Hospital, AntwerpTerminatedPain, Postoperative | Anesthesia | Hypnosis | Virtual Reality | Knee ArthropathyBelgium
-
University of LiegeOncomfort; BiowinNot yet recruiting
-
University of LiegeUnknownPain, Postoperative | Fatigue | Anxiety | Thoracic SurgeryBelgium
-
Clinique Saint-Jean, BruxellesCompleted
-
University of LiegeOncomfort; BiowinCompletedHealthy VolunteersBelgium
-
National Institute of General Medical Sciences...Completed
-
University of LiegeCompletedKnee Osteoarthritis | Arthroplasty Complications | Sedation Complication | Anesthesia Complication | Hypnotic; Anxiety DisorderBelgium